Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

NCT04989803 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed and/or Refractory B-cell Lymphoma

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: KITE-363
BIOLOGICAL: KITE-753

Sponsor

Kite, A Gilead Company